NYSE:KAPA | Profit Breakdown | Kairos Pharma, LTD.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2023-09-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$1.42M-$1.39M
2026-03-31-$1.69M-$1.65M
2025-12-31-$1.42M-$1.37M
2025-09-30-$1.44M-$1.4M
2025-06-30-$1.46M-$1.42M
2025-03-31-$1.27M-$1.26M
2024-12-31-$1.45M-$980,000.00
2024-09-30-$383,000.00-$1.05M
2024-06-30-$222,000.00-$253,000.00
2024-03-31-$287,000.00-$323,000.00
2023-12-31-$1.09M-$1.12M
2023-09-30-$287,000.00-$312,000.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$5.57M-$5.45M
2024-12-31-$2.34M-$2.6M
2023-12-31-$1.71M-$1.81M